drugset / Trial / NCT00143026

Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States

NCT00143026

Phase 4 Completed 184 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

This study examines the effect of treatment of levodopa/entacapone on quality of life, as measured by the Parkinson's Disease-Questionnaire 8 (PDQ-8), in Parkinson's disease patients with no or minimal, non-disabling motor fluctuations.

Timeline

Start
2005-07
Primary completion
2006-06
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Entacapone Small molecule
Background Carbidopa Unknown
Background Levodopa Small molecule

Indications